Patent details
301201
Product Name:
Asciminib of een farmaceutisch aanvaardbaar zout daarvan, zoals asciminibhydrochloride
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
301201
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2861579
Status:
SPC granted but not yet in force
Application number:
301201
Procedural language:
Dutch
First Applicant Residence Country:
Switzerland (CH)
Marketing Authorization
Marketing Authorization Number:
EU/1/22/1670
Marketing Authorization Type:
EEA
Marketing Authorization Date:
26/08/2022
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
26/10/2022
First Marketing Authorization date:
26/08/2022
Grant date:
07/12/2022
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
26/10/2022
SPC/SPC Extension Expiration Date:
25/08/2037
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
26/10/2022
Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, BASEL, Switzerland (CH)
Agent
1
Name:
ir. B.Ch. Ledeboer c.s
From:
28/07/2025
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
2
Name:
ir. H.A. Witmans c.s.
From:
26/10/2022
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
28/07/2025
Publication
Bulletin
1
Bulletin Heading:
SPC
Journal edition number:
50/22
Publication date:
14/12/2022
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
2
Bulletin Heading:
SPC
Journal edition number:
44/22
Publication date:
02/11/2022
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Annual Fee
Annual Fee(s) Due Date:
31/05/2033
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date
Document type
Document Description
Number of pages
File Type
07/12/2022
Outgoing Correspondence
Decision grant
1
PDF
/4/4/4/2/3/0800832444/docs/301201_0_518849l504a.pdf
07/12/2022
Certificate
Certificate
1
PDF
/4/4/4/2/3/0800832444/docs/301201_1_spcmedcertificate20221207102620965.pdf
26/10/2022
Application Form
First filed application form
3
PDF
/4/4/4/2/3/0800832444/docs/301201_2_applicationform20221026011829881.pdf
26/10/2022
SPC Documents
Marketing Authorization SPC
3
PDF
/4/4/4/2/3/0800832444/docs/301201_3_supplprotectioncertificate20221026012529567.pdf
26/10/2022
SPC Documents
Summary of the characteristics of the product
17
PDF
/4/4/4/2/3/0800832444/docs/301201_4_supplprotectioncertificate20221026012529585.pdf
26/10/2022
SPC Documents
Annex SPC
2
PDF
/4/4/4/2/3/0800832444/docs/301201_5_supplprotectioncertificate20221026012529607.pdf
26/10/2022
SPC Documents
Accompanying letter SPC
4
PDF
/4/4/4/2/3/0800832444/docs/301201_6_supplprotectioncertificate20221026012529548.pdf
26/10/2022
SPC Documents
Annex SPC
18
PDF
/4/4/4/2/3/0800832444/docs/301201_7_supplprotectioncertificate20221026012529634.pdf
26/10/2022
SPC Documents
Annex SPC
4
PDF
/4/4/4/2/3/0800832444/docs/301201_8_supplprotectioncertificate20221026012529659.pdf
26/10/2022
Outgoing Correspondence
Confirmation receipt request
1
PDF
/4/4/4/2/3/0800832444/docs/301201_9_511230l174.pdf